The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis
Open accessAbstract
OBJECTIVE: To determine the association between exposure to radiotherapy for the treatment of prostate cancer and subsequent second malignancies (second primary cancers). DESIGN: Systematic review and meta-analysis of observational studies. DATA SOURCES: Medline and Embase up to 6 April 2015 with no restrictions on year or language. STUDY SELECTION: Comparative studies assessing the risk of second malignancies in patients exposed or unexposed to radiotherapy in the course of treatment for prostate cancer were selected by two reviewers independently with any disagreement resolved by consensus. DATA EXTRACTION AND SYNTHESIS: Two reviewers independently extracted study characteristics and outcomes. Risk of bias was assessed with the Newcastle-Ottawa scale. Outcomes were synthesized with random effects models and Mantel-Haenszel weighting. Unadjusted odds ratios and multivariable adjusted hazard ratios, when available, were pooled. MAIN OUTCOME MEASURES: Second cancers of the bladder, colorectal tract, rectum, lung, and hematologic system. RESULTS: Of 3056 references retrieved, 21 studies were selected for analysis. Most included studies were large multi-institutional reports but had moderate risk of bias. The most common type of radiotherapy was external beam; 13 studies used patients treated with surgery as controls and eight used patients who did not undergo radiotherapy as controls. The length of follow-up among studies varied. There was increased risk of cancers of the bladder (four studies; adjusted hazard ratio 1.67, 95% confidence interval 1.55 to 1.80), colorectum (three studies; 1.79, 1.34 to 2.38), and rectum (three studies; 1.79, 1.34 to 2.38), but not cancers of the hematologic system (one study; 1.64, 0.90 to 2.99) or lung (two studies; 1.45, 0.70 to 3.01), after radiotherapy compared with the risk in those unexposed to radiotherapy. The odds of a second cancer varied depending on type of radiotherapy: treatment with external beam radiotherapy was consistently associated with increased odds while brachytherapy was not. Among the patients who underwent radiotherapy, from individual studies, the highest absolute rates reported for bladder, colorectal, and rectal cancers were 3.8%, 4.2%, and 1.2%, respectively, while the lowest reported rates were 0.1%, 0.3%, and 0.3%. CONCLUSION: Radiotherapy for prostate cancer was associated with higher risks of developing second malignancies of the bladder, colon, and rectum compared with patients unexposed to radiotherapy, but the reported absolute rates were low. Further studies with longer follow-up are required to confirm these findings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Engin Üstün, Y. (n.d.) · DergiPark (Istanbul University) · Cited by 170,090
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.005 · Cited by 19,575
(2014) · Medical Entomology and Zoology · Cited by 17,633
Evaluating non-randomised intervention studies
Deeks, J., Dinnes, J., D'Amico, R., Sowden, A., Sakarovitch, C., Song, F., Petticrew, M., & Altman, D. (2003) · Health Technology Assessment · doi:10.3310/hta7270 · Cited by 2,907
(2013) · Gastroenterology Research · doi:10.1053/j · Cited by 2,759
Heidenreich, A., Bastian, P. J., Bellmunt, J., Bolla, M., Joniau, S., van der Kwast, T., Mason, M., Matveev, V., Wiegel, T., Zattoni, F., et al. (2014) · European Urology · doi:10.1016/j.eururo.2013.09.046 · Cited by 1,936
Coiffier, B., Osmanov, E. A., Hong, X., Scheliga, A. A. D. S., Mayer, J., Offner, F., Rule, S. A., Teixeira, A., Walewski, J. A., Vos, S., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045 · Cited by 1,631
Sarcoma in irradiated bone. Report of eleven cases
Cahan, W. G., Woodard, H. Q., Higinbotham, N. L., Stewart, F. W., & Coley, B. L. (1948) · Cancer · doi:10.1002/1097-0142(194805)1:1<3::aid-cncr2820010103>3.0.co;2-7 · Cited by 1,095
Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer
Resnick, M. J., Koyama, T., Fan, K.-H., Albertsen, P. C., Goodman, M., Hamilton, A. S., Hoffman, R. M., Potosky, A. L., Stanford, J. L., Stroup, A. M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209978 · Cited by 979
Cluster-Randomized Trial to Increase Hepatitis B Testing among Koreans in Los Angeles
Bastani, R., Glenn, B. A., & Maxwell, A. E. (2015) · eCite Digital Repository (University of Tasmania) · doi:10.1158/1055-9965 · Cited by 901
Potosky, A. L., Davis, W. W., Hoffman, R. M., Stanford, J. L., Stephenson, R. A., Penson, D. F., & Harlan, L. C. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh259 · Cited by 680
Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery
Brenner, D. J., Curtis, R. E., Hall, E. J., & Ron, E. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000115)88:2<398::aid-cncr22>3.0.co;2-v · Cited by 618
Azzam, E. I., de Toledo, S. M., Gooding, T., & Little, J. B. (1998) · Radiation Research · doi:10.2307/3579865 · Cited by 521
de Gonzalez, A. B., Curtis, R. E., Kry, S. F., Gilbert, E., Lamart, S., Berg, C. D., Stovall, M., & Ron, E. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70061-4 · Cited by 481
Robins, J., Breslow, N., & Greenland, S. (1986) · Biometrics · doi:10.2307/2531052 · Cited by 476
Narayanan, P. K., Goodwin, E. H., & Lehnert, B. E. (1997) · PubMed · Cited by 461
Influence of obesity on the risk of developing colon cancer
Frezza, E. E., Wachtel, M. S., & Chiriva-Internati, M. (2006) · Gut · doi:10.1136/gut.2005.073163 · Cited by 345
Cost Implications of the Rapid Adoption of Newer Technologies for Treating Prostate Cancer
Nguyen, P. L., Gu, X., Lipsitz, S. R., Choueiri, T. K., Choi, W. W., Lei, Y., Hoffman, K. E., & Hu, J. C. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.1217 · Cited by 308
Lehnert, B. E., Goodwin, E. H., & Deshpande, A. (1997) · PubMed · Cited by 262
Increased risk of rectal cancer after prostate radiation: A population-based study
Baxter, N. N., Tepper, J. E., Durham, S. B., Rothenberger, D. A., & Virnig, B. A. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.038 · Cited by 224
Nam, R. K., Cheung, P., Herschorn, S., Saskin, R., Su, J., Klotz, L. H., Chang, M., Kulkarni, G. S., Lee, Y., Kodama, R. T., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70606-5 · Cited by 224
Self-citationHeight, body mass index, and prostate cancer: a follow-up of 950 000 Norwegian men
Engeland, A., Tretli, S., & Bjørge, T. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601206 · Cited by 217
Nieder, A. M., Porter, M. P., & Soloway, M. S. (2008) · Journal of Urology · doi:10.1016/j.juro.2008.07.038 · Cited by 195
Postradiation sarcomas: 20 cases and a literature review
Murray, E. M., Werner, D., Greeff, E. A., & Taylor, D. A. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00279-5 · Cited by 189
Alpha Particles Induce the Production of Interleukin-8 by Human Cells
Narayanan, P. K., LaRue, K. E. A., Goodwin, E. H., & Lehnert, B. E. (1999) · Radiation Research · doi:10.2307/3580049 · Cited by 189
Risk of second primary tumors in men diagnosed with prostate cancer: A population‐based cohort study
Davis, E. J., Beebe‐Dimmer, J., Yee, C. L., & Cooney, K. A. (2014) · Cancer · doi:10.1002/cncr.28769 · Cited by 122
Bhojani, N., Umberto Capitanio, A., Suardi, N. R., Claudio Jeldres, A., Hendrik Isbarn, A., Shariat, S. F., Graefen, M., Arjane, P., Duclos, A. J., Lattouf, J., et al. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.02.011 · Cited by 105
Secondary Cancer After Radiotherapy for Prostate Cancer: Should We Be More Aware of the Risk?
Boström, P. J., & Soloway, M. S. (2007) · European Urology · doi:10.1016/j.eururo.2007.07.002 · Cited by 98
Kendal, W. S., Eapen, L. J., MacRae, R. M., Malone, S. C., & Nicholas, G. A. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.11.013 · Cited by 93
Increased risk of colon cancer after external radiation therapy for prostate cancer
Rapiti, E., Fioretta, G., Verkooijen, H. M., Zanetti, R., Schmidlin, F. R., Schubert, H., Merglen, A., Miralbell, R., & Bouchardy, C. (2008) · International Journal of Cancer · doi:10.1002/ijc.23601 · Cited by 77
The characteristics of bladder cancer after radiotherapy for prostate cancer
Abern, M. R., Dude, A., Tsivian, M., & Coogan, C. L. (2012) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2012.04.006 · Cited by 70
Wallis, C. J. D., Cheung, P., Herschorn, S., Saskin, R., Su, J., Klotz, L. H., Kulkarni, G. S., Lee, Y. M., Kodama, R. T., Narod, S. A., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.54 · Cited by 40
Self-citationWallis, C. J. D., Herschorn, S., Saskin, R., Su, J., Klotz, L. H., Chang, M., Kulkarni, G. S., Lee, Y., Kodama, R. T., Narod, S. A., et al. (2015) · Urology · doi:10.1016/j.urology.2014.11.037 · Cited by 39
Self-citationRadiation Therapy for Prostate Cancer Increases the Risk of Subsequent Rectal Cancer
Margel, D., Baniel, J., Wasserberg, N., Barchana, M., & Yossepowitch, O. (2011) · Annals of Surgery · doi:10.1097/sla.0b013e3182382fd5 · Cited by 39
Singh, A. K., Mashtare, T. L., McCloskey, S. A., Seixas‐Mikelus, S. A., Kim, H. L., & May, K. S. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.09.055 · Cited by 34
Cited by
Mottet, N., Bellmunt, J., Bolla, M., Briers, E., Cumberbatch, M. G., De Santis, M., Fossati, N., Gross, T., Henry, A. M., Joniau, S., et al. (2017) · European Urology · doi:10.1016/j.eururo.2016.08.003 · Cited by 3,227
Mottet, N., van den Bergh, R. C. N., Briers, E., Van den Broeck, T., Cumberbatch, M. G., De Santis, M., Fanti, S., Fossati, N., Gandaglia, G., Gillessen, S., et al. (2021) · European Urology · doi:10.1016/j.eururo.2020.09.042 · Cited by 2,802
Lenis, A. T., Lec, P. M., Chamie, K., & MSHS, M. (2020) · JAMA · doi:10.1001/jama.2020.17598 · Cited by 2,051
Cornford, P., van den Bergh, R. C. N., Briers, E., Van den Broeck, T., Brunckhorst, O., Darraugh, J., Eberli, D., De Meerleer, G., De Santis, M., Farolfi, A., et al. (2024) · European Urology · doi:10.1016/j.eururo.2024.03.027 · Cited by 1,246
Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018
Cumberbatch, M. G. K., Jubber, I., Black, P. C., Esperto, F., Figueroa, J. D., Kamat, A. M., Kiemeney, L., Lotan, Y., Pang, K., Silverman, D. T., et al. (2018) · European Urology · doi:10.1016/j.eururo.2018.09.001 · Cited by 820
Metadata
- Authors
- Wallis, C. J. D., Mahar, A. L., Choo, R., Herschorn, S., Kodama, R. T., Shah, P. S., Danjoux, C., Narod, S. A., & Nam, R. K.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2016-03-02
- Volume
- 352
- Pages
- i851
- ISSN
- 1756-1833 (ISSN-L)
- OpenAlex
- W2294907556
- Cited by
- 271
- References
- 39
- FWCI
- 4.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.